MVision AI is a healthcare technology company specializing in AI-powered solutions for radiotherapy treatment planning. Their flagship product, Contour+, automates the delineation of organs-at-risk and lymph nodes on CT and MR scans, significantly reducing manual effort and enhancing consistency in treatment planning. By integrating seamlessly with existing treatment planning systems, MVision AI's solutions streamline workflows, enabling clinicians to deliver high-quality, guideline-compliant care more efficiently. The company's technology is utilized in over 20 countries, supporting radiation oncologists, therapists, medical physicists, and clinical scientists in providing faster and more accurate cancer treatments. Key Features and Functionality: - Contour+: An AI-driven automatic segmentation tool that provides precise delineation of organs-at-risk and lymph node areas, aiding in the creation of high-quality treatment plans. - Workspace+ Platform: A comprehensive platform unifying contouring, synthetic imaging, dose prediction, and contour propagation, designed for seamless integration with existing treatment planning systems. - GBS™ Solution: Combines Contour+, Guide, and Verify to standardize contours, reduce variability, and enhance contouring expertise through training and assessment. Primary Value and Problem Solved: MVision AI addresses the challenges of manual contouring in radiotherapy, which is time-consuming and prone to variability. By automating this process, their solutions reduce manual work time by up to 95% and increase consistency by an average of 20%. This leads to faster treatment planning, reduced patient waiting times, and improved treatment outcomes, ultimately enhancing the efficiency and effectiveness of cancer care.